IRIS
STRIANO, PASQUALE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 65.922
AS - Asia 86
SA - Sud America 49
NA - Nord America 9
Totale 66.066
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 65.918
CN - Cina 47
BR - Brasile 42
VN - Vietnam 21
SG - Singapore 16
US - Stati Uniti d'America 8
AR - Argentina 3
EC - Ecuador 3
FI - Finlandia 3
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
GY - Guiana 1
ID - Indonesia 1
Totale 66.066
Salva come PNG Salva come JPEG
Città #
Genova 39.689
Genoa 17.114
Rapallo 4.658
Vado Ligure 4.372
Bordighera 82
Beijing 22
Singapore 13
Ashburn 8
Ho Chi Minh City 6
Hanoi 4
Belo Horizonte 3
Da Nang 3
Lappeenranta 3
Milan 3
Haiphong 2
Quito 2
São Paulo 2
Anápolis 1
Baku 1
Balneário Camboriú 1
Benito Juárez 1
Bragança Paulista 1
Brasília 1
Can Tho 1
Caxias 1
Congonhas 1
Criciúma 1
Eldorado do Sul 1
Florianópolis 1
Formosa 1
General Rodríguez 1
Georgetown 1
Governador Valadares 1
Guarujá 1
Guarulhos 1
Imperatriz 1
Jacuí 1
Jaguariaíva 1
Jandira 1
Jarinu 1
Juatuba 1
Jundiaí 1
Lambari 1
Lauro de Freitas 1
Lấp Vò 1
Manaus 1
Paulínia 1
Ribeirão Preto 1
Riobamba 1
Salto de Pirapora 1
Samarinda 1
Santa Inês 1
Santa Luzia 1
Santo André 1
Santos 1
São Bernardo do Campo 1
São Caetano do Sul 1
São Gonçalo 1
São Luís 1
São Luís do Curu 1
Tangará da Serra 1
Terra Nova 1
Thái Nguyên 1
Toronto 1
Uberlândia 1
Vinh 1
Việt Trì 1
Zenica 1
Totale 66.037
Salva come PNG Salva come JPEG
Nome #
(1)H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy. 1.362
"Comorbidity" between epilepsy and headache/migraine: the other side of the same coin! 228
A de novo 11p12-p15.4 duplication in a patient with pharmacoresistant epilepsy, mental retardation, and dysmorphisms. 225
A 3-year-old boy with drug-resistant complex partial seizures 200
6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases. 200
A novel SCN2A mutation in family with benign familial infantile seizures. 199
A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. 196
A new benign adult familial myoclonic epilepsy (BAFME) pedigree suggesting linkage to chromosome 2p11.1-q12.2. 196
22-year-old girl with status epilepticus and progressive neurological symptoms. 193
Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. 193
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 187
Whole-genome linkage scan for epilepsy-related photosensitivity: a mega-analysis. 182
'Autoimmune epilepsy' or exasperated search for the etiology of seizures of unknown origin? 181
Pyridoxine-dependent epilepsy: An under-recognised cause of intractable seizures. 178
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 177
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). 175
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome. 173
Similar but not identical: clinical implications for molecular studies in monozygotic discordant twins with epilepsy. 172
Recurrent hypothermia with hyperhidrosis in two siblings: familial Shapiro syndrome variant. 171
Clinical and genetic findings in 26 Italian patients with Lafora disease. 170
End-of-life: still an Italian dilemma. 170
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. 170
A t(4;9)(q34;p22) translocation associated with partial epilepsy, mental retardation, and dysmorphism. 169
Epileptogenesis due to peripheral injury as a cause of focal epilepsy. 169
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 169
Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity. 168
Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. 168
Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. 168
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability 168
Lumping encephalopathies with inflammation-mediated status epilepticus: is there enough evidence? 167
Idiopathic mesial temporal lobe epilepsy: don't sow the tares with the wheat! 165
LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. 165
Do regulatory regions matter in FOXG1 duplications? 165
Epileptic myoclonus as ciprofloxacin-associated adverse effect. 164
Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases. 164
Dissecting the neurological phenotype in children with callosal agenesis, interhemispheric cysts and malformations of cortical development 164
No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy 164
The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies. 163
Long-term evolution of EEG in Unverricht-Lundborg disease. 163
From migralepsy to ictal epileptic headache: the story so far. 163
A clinical and genetic study of 33 new cases with early-onset absence epilepsy. 163
Long-term follow-up in two siblings with pyridoxine-dependent seizures associated with a novel ALDH7A1 mutation. 161
Sudden death in Unverricht-Lundborg patients: is serotonin the key? 161
Suppression of myoclonus in SCA2 by piracetam. 161
Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter study 161
Comment to: Diabetic hyperglycemia is associated with the severity of epileptic seizures in adults. 160
Clinical features of Sturge-Weber syndrome without facial nevus: Five novel cases. 159
"Ictal epileptic headache": Beyond the epidemiological evidence. 159
What have we learned about ictal epileptic headache? A review of well-documented cases. 159
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 159
Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. 158
'Ictal epileptic headache': Recent concepts for new classifications criteria. 158
Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy 158
A proof-of-concept trial of the whey protein alfa-lactalbumin in chronic cortical myoclonus. 158
Inferior olivary nucleus involvement in pediatric neurodegenerative disorders: does it play a role in neuroimaging pattern-recognition approach? 158
Epilepsy associated with supratentorial brain tumors under 3 years of life. 157
De novo mutations in HCN1 cause early infantile epileptic encephalopathy 157
Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. 156
Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients. 156
TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy 156
Migralepsy, hemicrania epileptica, post-ictal headache and "ictal epileptic headache": a proposal for terminology and classification revision. 156
The gelastic seizures-hypothalamic hamartoma syndrome: Facts, hypotheses, and perspectives. 156
Idiopathic focal epilepsies: the "lost tribe" 156
Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients. 155
Functional changes in hypothalamic hamartoma neurons and gelastic epilepsy. 154
GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features. 154
Reflex seizures and reflex epilepsies: Old models for understanding mechanisms of epileptogenesis. 154
Lateralizing value of the auditory aura in partial seizures. 154
Comment to: overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy. 154
De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. 154
Willful modulation of brain activity in disorders of consciousness. 153
Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients. 153
Galloway-Mowat syndrome: an early-onset progressive encephalopathy with intractable epilepsy associated to renal impairment. Two novel cases and review of literature. 153
Clinical and electrophysiological features of epilepsy in Italian patients with CLN8 mutations. 152
Evaluation of presumably disease causing SCN1A variants in a cohort of common epilepsy syndromes 152
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. 151
Epilepsy: old drugs do the trick in childhood absence epilepsy. 151
Linkage analysis and disease models in benign familial infantile seizures: a study of 16 families. 151
Benign adult familial myoclonic epilepsy (BAFME): evidence of an extended founder haplotype on chromosome 2p11.1-q12.2 in five Italian families. 151
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. 151
Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. 150
Commentary to: "Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid". 150
Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. 150
Eyelid myoclonia with absences: an overlooked epileptic syndrome? 150
Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution. 150
Metabolic and endocrine effects of valproic acid chronic treatment. 150
Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome. 150
NovelAMPD2mutation in pontocerebellar hypoplasia, dysmorphisms, and teeth abnormalities 150
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 150
Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature. 149
The saga of Eluana Englaro: another tragedy feeding the media. 149
New terminology for headache/migraine as the sole ictal epileptic manifestation: the downsides. Reply to Cianchetti et al. 149
Familial nonkinesigenic paroxysmal dyskinesia and intracranial calcifications: a new syndrome? 149
DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy 149
ABCC6 mutations and early onset stroke: Two cases of a typical Pseudoxanthoma Elasticum 149
Comment to: addition of verapamil in the treatment of severe myoclonic epilepsy in infancy (Iannetti et al.). 148
Epileptic seizures can follow high doses of oral vardenafil. 148
Somatic and germline mosaicisms in Severe Myoclonic Epilepsy of Infancy 147
Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis 147
Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome 147
Totale 17.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 247.072
article - articoli 243.611
book - libri 227
conference - conferenze 483
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.751
Totale 494.144
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.682 0 0 0 1.962 201 361 374 882 434 1.175 760 533
2021/20226.787 298 281 1.012 439 234 353 338 1.512 381 664 431 844
2022/20235.777 746 257 68 457 876 1.067 40 475 1.159 50 479 103
2023/20243.514 229 477 106 334 262 490 162 148 288 170 282 566
2024/202511.019 326 913 278 612 1.575 1.132 1.069 1.396 594 707 1.030 1.387
2025/20266.252 2.135 678 2.096 1.343 0 0 0 0 0 0 0 0
Totale 67.208